Document is current
Any future updates will be listed below
-
Authors
Ebrahimi, Moein https://orcid.org/0000-0001-6166-1492
Sivaprasad, Sobha
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim
- License Information
-
More Information
Article History
Received: 28 March 2024
Revised: 15 May 2024
Accepted: 19 June 2024
First Online: 15 July 2024
Competing interests
: SS reported receiving financial support from AbbVie, Amgen, Apellis, Astellas, Bayer, Biogen, Boehringer Ingelheim, Eyebiotech, Eyepoint Phamaceuticals, Iveric Bio, Janssen Pharmaceuticals, Nova Nordisk, Optos, Ocular Therapeutix, Kriya Therapeutics, OcuTerra, Roche, Stealth Biotherapeutics and Sanofi. SS is a member of the Eye editorial board. ME has no conflicts of interest.
